AI assistant
GlaxoSmithKline PLC — Director's Dealing 2016
Jul 20, 2016
5262_dirs_2016-07-20_68402e93-93c7-439c-bf6b-f50078504c83.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 6642E
GlaxoSmithKline PLC
19 July 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
1.
Details of PDMR/person closely associated with them ('PCA')
a)
Name
Mr P C Thomson
b)
Position/status
SVP, Communications & Government Affairs
c)
Initial notification/
amendment
Initial notification
2.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
GlaxoSmithKline plc
b)
LEI
5493000HZTVUYLO1D793
3.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)
Description of the financial instrument
Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882
b)
Nature of the transaction
Increase in notional interest in Ordinary Shares following the re-investment of dividends paid to shareholders on 14 July 2016 on Ordinary Shares held in the Company's 2009 Performance Share Plan.
c)
Price(s) and
volume(s)
| Price(s) | Volume(s) |
| £16.285 | 525.551 |
| £16.285 | 676.931 |
| £16.285 | 741.793 |
d)
Aggregated information
Aggregated volume Price
1,944.275
£16.285
e)
Date of the transaction
2016-07-14
f)
Place of the transaction
n/a
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHVKLFFQDFBBBL
//<![CDATA[$.ajaxSetup({headers: {'__RequestVerificationToken':'IHXPp6u55auehCba9Zxz--xv8ged1iVemi6Jr01fVKBPFUycNQ9aRL40Q3pIrjBv3DjwLawgf_cctzLSIQRovQagAEP4h7njFiPmyyh8u2s1:wkQ1z1ZHugS9zT9o8CXm5DQGVE6M5_z_OZ5c3kLqqUGnCcSeo7AsTVt1MEj1mSTzQzjFV_d9wuh2jtx7GZDy45o7P0DaAlonPqwFYYnSrhc1'}});//]]>